MELD exceptions and rates of waiting list outcomes

A. B. Massie, B. Caffo, S. E. Gentry, E. C. Hall, D. A. Axelrod, K. L. Lentine, M. A. Schnitzler, A. Gheorghian, P. R. Salvalaggio, D. L. Segev

Research output: Contribution to journalArticlepeer-review

171 Scopus citations


Model for End-stage Liver Disease (MELD)-based allocation of deceased donor livers allows exceptions for patients whose score may not reflect their truemortality risk. We hypothesized that organ procurement organizations (OPOs) may differ in exception practices, use of exceptions may be increasing over time, and exception patients may be advantaged relative to other patients. We analyzed longitudinal MELD score, exception and outcome in 88 981 adult liver candidates as reported to the United Network for Organ Sharing from 2002 to 2010. Proportion of patients receiving an HCC exception was 0-21.4% at the OPO-level and 11.9-18.8% at the region level; proportion receiving an exception for other conditions was 0.0% -13.1% (OPOlevel) and 3.7-9.5 (region-level). Hepatocellular carcinoma (HCC) exceptions rose over time (10.5% in 2002 vs. 15.5% in 2008, HR = 1.09 per year, p<0.001) as did other exceptions (7.0% in 2002 vs. 13.5% in 2008, HR = 1.11, p<0.001). In the most recent era of HCC point assignment (since April 2005), both HCC and other exceptions were associated with decreased risk of waitlist mortality compared to nonexception patients with equivalent listing priority (multinomial logistic regression odds ratio [OR] = 0.47 for HCC, OR = 0.43 for other, p<0.001) and increased odds of transplant (OR = 1.65 for HCC, OR = 1.33 for other, p<0.001). Policy advantages patientswithMELD exceptions; differing rates of exceptions by OPO may create, or reflect, geographic inequity.

Original languageEnglish (US)
Pages (from-to)2362-2371
Number of pages10
JournalAmerican Journal of Transplantation
Issue number11
StatePublished - Nov 2011


  • Liver transplantation
  • MELD score
  • Organ allocation

ASJC Scopus subject areas

  • Immunology and Allergy
  • Transplantation
  • Pharmacology (medical)


Dive into the research topics of 'MELD exceptions and rates of waiting list outcomes'. Together they form a unique fingerprint.

Cite this